Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin’s lymphoma in a developing country?

By Ruiz-Delgado Guillermo J   Gómez-Almaguer David   Tarín-Arzaga Luz C   Cantú-Rodriguez Olga G   Urdaneta Carlos Alarcón   Rodríguez-Morales Uxmal   Calderón-Garcia Jackeline   Fernández-Vargas Omar   Montes-Montiel Maryel   Sánchez-Cárdenas Mónica   Ruiz-Argüelles Guillermo J  

Hematology, Vol. 17, Iss. 4, 2012-07 ,pp. : 193-197

Maney Publishing

Access to resources Recommend Favorite

Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma

By Hess Georg   Flohr Thomas   Kolbe Karin   Bonn Sarah   Schuler Martin   Derigs Hans   Huber Christoph  

Annals of Hematology, Vol. 85, Iss. 11, 2006-11 ,pp. : 769-779

Springer Publishing Company

Access to resources Recommend Favorite

Tri-lineage disease involving sideroblastic anaemia, multiple myeloma and B-cell non-Hodgkin's lymphoma in the same patient

By Ianotto Jean-Christophe  

Annals of Hematology, Vol. 88, Iss. 3, 2009-03 ,pp. : 273-274

Springer Publishing Company

Access to resources Recommend Favorite

CD8 expression in B-cell non-Hodgkin’s lymphomas

By Carulli Giovanni  

Annals of Hematology, Vol. 87, Iss. 7, 2008-07 ,pp. : 577-579

Springer Publishing Company

Access to resources Recommend Favorite

Successful treatment with lamivudine for reactivated hepatitis B infection following chemotherapy for non-Hodgkin's lymphoma

By Stroffolini T.   Andriani A.   Bibas M.   Barlattani A.  

Annals of Hematology, Vol. 81, Iss. 1, 2002-01 ,pp. : 48-49

Springer Publishing Company

Access to resources Recommend Favorite